医薬品用ゼラチン市場：世界の市場規模、シェア、動向分析、機会、予測レポート、2019-2029年

医薬品用ゼラチンの世界市場規模は2029年までに18億米ドルに達する

世界の医薬品用ゼラチン市場は、慢性疾患の増加、ゼラチンの良好な特性、先進的な医薬品用ゼラチンの発売など、管理への注目が高まっているため、活況を呈しています。

大手戦略コンサルティング・市場調査会社のBlueWeave Consultingは最近の調査で、2022年の世界の医薬品用ゼラチン市場規模を12億2,000万米ドルと推定しました。2023年から2029年の予測期間中、BlueWeaveは世界の医薬品用ゼラチン市場規模がCAGR 5.48%で成長し、2029年には17億6,000万米ドルに達すると予測しています。医薬品用ゼラチンの世界市場の主な成長促進要因には、医薬品グレードのゼラチンに対するニーズの高まり、慢性疾患の新興国市場の拡大、世界人口の急速な高齢化、医薬品やワクチンにおけるゼラチンナノ粒子の利用における市場開拓の進展などがあります。化粧品用途でのゼラチンの利用拡大、ゼラチン固有の機能性、創傷被覆・治癒、遺伝子治療、組織工学、インプラント、骨代替物などの生物医学的用途が、市場の拡大にさらに拍車をかけています。また、ドラッグデリバリー目的でのゼラチン利用が進んでいることも、予測期間中の医薬品用ゼラチン市場の拡大を後押しするとみられます。しかし、非ゼラチンカプセルへのシフトが市場全体の成長を妨げると予測されています。

本レポートの詳細な分析により、世界の医薬品用ゼラチン市場の成長可能性、今後の動向、統計に関する情報を提供します。また、総市場規模の予測を促進する要因にも注目しています。当レポートは、世界の医薬品用ゼラチン市場の最新技術動向や、意思決定者が健全な戦略的意思決定を行えるような業界洞察の提供をお約束します。さらに、市場の成長促進要因・課題・競争力学についても分析しています。

目次

第1章 調査の枠組み

第2章 エグゼクティブサマリー

第3章 世界の医薬品用ゼラチン市場に関する洞察

• 業界のバリューチェーン分析
• DROC分析
  • 成長の原動力
    • ゼラチンの利点と特性
    • アドバンストファーマゼラチンの発売
  • 抑制要因
    • 非ゼラチンカプセルへの移行
  • 機会
    • 新興諸国における医薬品用ゼラチンの需要
  • 課題
    • ゼラチンのコストが高い
• 技術の進歩/最近の開発
• 規制の枠組み
• ポーターのファイブフォース分析

第4章 世界の医薬品用ゼラチン市場概要

• 市場規模と予測、2019～2029年
  • 金額別
• 市場シェアと予測
  • ソース別
    • ブタ
    • ウシの皮
    • ウシの骨
    • 海洋
    • 家禽
  • 機能別
    • 安定化剤
    • 増粘剤
    • ゲル化剤
    • その他
  • タイプ別
    • タイプA
    • タイプB
  • 用途別
    • ハードカプセル
    • ソフトジェルカプセル
    • 錠剤
    • 吸収性止血剤
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋（APAC）
    • ラテンアメリカ（LATAM）
    • 中東およびアフリカ（MEA）

第5章 北米の医薬品用ゼラチン市場

• 市場規模と予測、2019～2029年
  • 金額別
• 市場シェアと予測
  • ソース別
  • 機能別
  • タイプ別
  • 用途別
  • 国別
    • 米国
    • カナダ

第6章 欧州の医薬品用ゼラチン市場

• 市場規模と予測、2019～2029年
  • 金額別
• 市場シェアと予測
  • ソース別
  • 機能別
  • タイプ別
  • 用途別
  • 国別
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • ベルギー
    • ロシア
    • オランダ
    • その他欧州

第7章 アジア太平洋の医薬品用ゼラチン市場

• 市場規模と予測、2019～2029年
  • 金額別
• 市場シェアと予測
  • ソース別
  • 機能別
  • タイプ別
  • 用途別
  • 国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリアとニュージーランド
    • インドネシア
    • マレーシア
    • シンガポール
    • ベトナム
    • APACのその他諸国

第8章 ラテンアメリカの医薬品用ゼラチン市場

• 市場規模と予測、2019～2029年
  • 金額別
• 市場シェアと予測
  • ソース別
  • 機能別
  • タイプ別
  • 用途別
  • 国別
    • ブラジル
    • メキシコ
    • アルゼンチン
    • ペルー
    • 中南米の残りの地域

第9章 中東およびアフリカの医薬品用ゼラチン市場

• 市場規模と予測、2019～2029年
  • 金額別
• 市場シェアと予測
  • ソース別
  • 機能別
  • タイプ別
  • 用途別
  • 国別
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • クウェート
    • 南アフリカ
    • ナイジェリア
    • アルジェリア
    • MEAの残りの部分

第10章 競合情勢

• 主要人物とその情報源のリスト
• 世界の製薬ゼラチン企業の市場シェア分析、2022年
• 経営パラメータ別競合ベンチマーキング
• 主要な戦略的展開（合併、買収、パートナーシップなど）

第11章 世界の医薬品用ゼラチン市場に対するCOVID-19の影響

第12章 企業プロファイル（会社概要、財務マトリックス、競合情勢、主要な人材、主要な競合、連絡先住所、戦略的展望、 SWOT分析）

• Gelita AG
• Trobas Pharmaceutical gelatine B.V
• Rousselot
• Weishardt
• Sterling Gelatin
• Catalent, Inc
• Nitta Pharmaceutical gelatin India Limited
• Aspire Pharmaceuticals
• Junca Gelatines
• Gelco International
• Norland Products Inc
• Lapi Gelatine S.p.a
• Trobus Gelatine B.V.
• Other Prominent Players

第13章 主要な戦略的推奨事項

第14章 調査手法

Global Pharmaceutical Gelatin Market Size Set to Touch USD 1.8 Billion by 2029.

Global pharmaceutical gelatin market is flourishing because of the growing focus on the management of increasing prevalence of chronic illnesses, favorable properties of gelatin, and the launch of advanced pharma gelatin.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated global pharmaceutical gelatin market size at USD 1.22 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the global pharmaceutical gelatin market size to grow at a CAGR of 5.48% reaching a value of USD 1.76 billion by 2029. Major growth drivers for the global pharmaceutical gelatin market include an increasing need for pharmaceutical-grade gelatin, the growing prevalence of chronic illnesses, rapidly aging world population, and the progressing developments in the utilization of gelatin nanoparticles in medications and vaccines. The expanding utilization of gelatin in cosmetic applications, its inherent functionalities, as well as its biomedical applications in wound dressing and healing, gene therapy, tissue engineering, implants, and bone substitutes, are further fueling the expansion of the market. Also, the increasing progress in utilizing gelatin for drug delivery purposes is expected to propel the market expansion of pharmaceutical gelatin during the forecast period. However, shift towards non-gelatin capsules is anticipated to hinder the overall market growth.

Global Pharmaceutical Gelatin Market - Overview:

Pharmaceutical gelatin, derived from collagen extracted from animal body parts, is a transparent, long-lasting, inherently tasteless, and odorless food product. It possesses a dry and brittle texture when dry, while being flexible and rubbery when moist. It finds extensive applications as a gelling agent in the pharmaceutical industry for drugs, vitamins, medicines, photographic films & documents, as well as cosmetics. The production process for hard gelatin capsules involves immersing them in a warm bath of gelatin solution, followed by drying, pinning, and cutting of cap and body components, which are then assembled for distribution. These capsules are typically filled with dry forms of pharmaceutical or supplemental products by pharmaceutical or health companies. On the other hand, the manufacturing of soft gelatin capsules begins with the creation of two sheets of soft gelatin, each passing through a die to achieve the desired capsule size and shape. During capsule production, the medication or health supplements are filled with a liquid dose simultaneously. The dose and layer can serve as binding agents to eliminate unpleasant taste and odor, while also facilitating product identification. The specific gelatin melt characteristic also plays a significant role in the controlled and rapid release of medicines. Gelatin is also utilized in the production of suppositories.

Impact of COVID-19 on Global Pharmaceutical Gelatin Market:

COVID-19 pandemic adversely affected the global pharmaceutical gelatin market. Initially, the market experienced disruptions in supply chains and production capacity limitations due to lockdowns, travel restrictions, and disruptions in transportation and logistics. These challenges led to difficulties in procuring raw materials for gelatin production and resulted in limited availability of pharmaceutical gelatin. Also, the pharmaceutical industry as a whole faced delays in clinical trials, regulatory approvals, and new product launches, which indirectly affected the demand for gelatin. However, as the pandemic situation improved and healthcare systems stabilized, the global pharmaceutical gelatin market started showing positive signs of recovery. There was a renewed focus on R&D, including the development of vaccines and therapeutics, which increased the demand for gelatin. Pharmaceutical companies began diversifying their supplier base and exploring alternative sourcing options to enhance supply chain resilience. The market witnessed a gradual rebound in demand for gelatin as healthcare needs resumed, and the industry adapted to the new normal.

Global Pharmaceutical Gelatin Market - By Function:

Based on function, the global pharmaceutical gelatin market is divided into Stabilizing Agent, Thickening Agent, and Gelling Agent segments. The stabilizing agent segment holds the highest share in the global pharmaceutical gelatin market. Stabilizing agents are essential components in the production of gelatin-based pharmaceutical formulations, as they help maintain the stability, integrity, and shelf life of the products. These agents prevent gelatin from undergoing degradation, aggregation, or changes in physical and chemical properties. They play a crucial role in ensuring the quality and efficacy of pharmaceutical gelatin in various applications, including capsules, coatings, and drug delivery systems. The high demand for stabilizing agents is driven by the need for reliable and consistent gelatin formulations that meet regulatory requirements and deliver optimal performance in pharmaceutical applications.

Competitive Landscape:

Major players operating in the global pharmaceutical gelatin market include: Gelita AG, Trobas Pharmaceutical gelatine B.V, Rousselot, Weishardt, Sterling Gelatin, Catalent, Inc, Nitta Pharmaceutical gelatin India Limited, Aspire Pharmaceuticals, Junca Gelatines, Gelco International, Norland Products Inc, Lapi Gelatine S.p.a, and Trobus Gelatine B.V. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Pharmaceutical Gelatin Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Pharmaceutical Gelatin Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

• 1.1. Research Objective
• 1.2. Source Overview
• 1.3. Market Segmentation

2. Executive Summary

3. Global Pharmaceutical Gelatin Market Insights

• 3.1. Industry Value Chain Analysis
• 3.2. DROC Analysis
  • 3.2.1. Growth Drivers
    • 3.2.1.1. Advantages & properties of Gelatin
    • 3.2.1.2. Launch of Advanced Pharma Gelatin
  • 3.2.2. Restraints
    • 3.2.2.1. Shift Towards Non-Gelatin Capsules
  • 3.2.3. Opportunities
    • 3.2.3.1. Demand of Pharma Gelatin in Developing Countries
  • 3.2.4. Challenges
    • 3.2.4.1. High Cost of Gelatins
• 3.3. Technology Advancements/Recent Developments
• 3.4. Regulatory Framework
• 3.5. Porter's Five Forces Analysis
  • 3.5.1. Bargaining Power of Suppliers
  • 3.5.2. Bargaining Power of Buyers
  • 3.5.3. Threat of New Entrants
  • 3.5.4. Threat of Substitutes
  • 3.5.5. Intensity of Rivalry

4. Global Pharmaceutical Gelatin Market Overview

• 4.1. Market Size & Forecast, 2019-2029
  • 4.1.1. By Value (USD Million)
• 4.2. Market Share & Forecast
  • 4.2.1. By Source
    • 4.2.1.1. Porcine
    • 4.2.1.2. Bovine Skin
    • 4.2.1.3. Bovine Bone
    • 4.2.1.4. Marine
    • 4.2.1.5. Poultry
  • 4.2.2. By Function
    • 4.2.2.1. Stabilizing Agent
    • 4.2.2.2. Thickening Agent
    • 4.2.2.3. Gelling Agent
    • 4.2.2.4. Others
  • 4.2.3. By Type
    • 4.2.3.1. Type A
    • 4.2.3.2. Type B
  • 4.2.4. By Application
    • 4.2.4.1. Hard Capsules
    • 4.2.4.2. Softgel Capsules
    • 4.2.4.3. Tablets
    • 4.2.4.4. Absorbable Hemostats
    • 4.2.4.5. Others
  • 4.2.5. By Region
    • 4.2.5.1. North America
    • 4.2.5.2. Europe
    • 4.2.5.3. Asia Pacific (APAC)
    • 4.2.5.4. Latin America (LATAM)
    • 4.2.5.5. Middle East and Africa (MEA)

5. North America Pharmaceutical Gelatin Market

• 5.1. Market Size & Forecast, 2019-2029
  • 5.1.1. By Value (USD Million)
• 5.2. Market Share & Forecast
  • 5.2.1. By Source
  • 5.2.2. By Function
  • 5.2.3. By Type
  • 5.2.4. By Application
  • 5.2.5. By Country
    • 5.2.5.1. United States
    • 5.2.5.1.1. By Source
    • 5.2.5.1.2. By Function
    • 5.2.5.1.3. By Type
    • 5.2.5.1.4. By Application
    • 5.2.5.2. Canada
    • 5.2.5.2.1. By Source
    • 5.2.5.2.2. By Function
    • 5.2.5.2.3. By Type
    • 5.2.5.2.4. By Application

6. Europe Pharmaceutical Gelatin Market

• 6.1. Market Size & Forecast, 2019-2029
  • 6.1.1. By Value (USD Million)
• 6.2. Market Share & Forecast
  • 6.2.1. By Source
  • 6.2.2. By Function
  • 6.2.3. By Type
  • 6.2.4. By Application
  • 6.2.5. By Country
    • 6.2.5.1. Germany
    • 6.2.5.1.1. By Source
    • 6.2.5.1.2. By Function
    • 6.2.5.1.3. By Type
    • 6.2.5.1.4. By Application
    • 6.2.5.2. United Kingdom
    • 6.2.5.2.1. By Source
    • 6.2.5.2.2. By Function
    • 6.2.5.2.3. By Type
    • 6.2.5.2.4. By Application
    • 6.2.5.3. Italy
    • 6.2.5.3.1. By Source
    • 6.2.5.3.2. By Function
    • 6.2.5.3.3. By Type
    • 6.2.5.3.4. By Application
    • 6.2.5.4. France
    • 6.2.5.4.1. By Source
    • 6.2.5.4.2. By Function
    • 6.2.5.4.3. By Type
    • 6.2.5.4.4. By Application
    • 6.2.5.5. Spain
    • 6.2.5.5.1. By Source
    • 6.2.5.5.2. By Function
    • 6.2.5.5.3. By Type
    • 6.2.5.5.4. By Application
    • 6.2.5.6. Belgium
    • 6.2.5.6.1. By Source
    • 6.2.5.6.2. By Function
    • 6.2.5.6.3. By Type
    • 6.2.5.6.4. By Application
    • 6.2.5.7. Russia
    • 6.2.5.7.1. By Source
    • 6.2.5.7.2. By Function
    • 6.2.5.7.3. By Type
    • 6.2.5.7.4. By Application
    • 6.2.5.8. The Netherlands
    • 6.2.5.8.1. By Source
    • 6.2.5.8.2. By Function
    • 6.2.5.8.3. By Type
    • 6.2.5.8.4. By Application
    • 6.2.5.9. Rest of Europe
    • 6.2.5.9.1. By Source
    • 6.2.5.9.2. By Function
    • 6.2.5.9.3. By Type
    • 6.2.5.9.4. By Application

7. Asia-Pacific Pharmaceutical Gelatin Market

• 7.1. Market Size & Forecast, 2019-2029
  • 7.1.1. By Value (USD Million)
• 7.2. Market Share & Forecast
  • 7.2.1. By Source
  • 7.2.2. By Function
  • 7.2.3. By Type
  • 7.2.4. By Application
  • 7.2.5. By Country
    • 7.2.5.1. China
    • 7.2.5.1.1. By Source
    • 7.2.5.1.2. By Function
    • 7.2.5.1.3. By Type
    • 7.2.5.1.4. By Application
    • 7.2.5.2. India
    • 7.2.5.2.1. By Source
    • 7.2.5.2.2. By Function
    • 7.2.5.2.3. By Type
    • 7.2.5.2.4. By Application
    • 7.2.5.3. Japan
    • 7.2.5.3.1. By Source
    • 7.2.5.3.2. By Function
    • 7.2.5.3.3. By Type
    • 7.2.5.3.4. By Application
    • 7.2.5.4. South Korea
    • 7.2.5.4.1. By Source
    • 7.2.5.4.2. By Function
    • 7.2.5.4.3. By Type
    • 7.2.5.4.4. By Application
    • 7.2.5.5. Australia & New Zealand
    • 7.2.5.5.1. By Source
    • 7.2.5.5.2. By Function
    • 7.2.5.5.3. By Type
    • 7.2.5.5.4. By Application
    • 7.2.5.6. Indonesia
    • 7.2.5.6.1. By Source
    • 7.2.5.6.2. By Function
    • 7.2.5.6.3. By Type
    • 7.2.5.6.4. By Application
    • 7.2.5.7. Malaysia
    • 7.2.5.7.1. By Source
    • 7.2.5.7.2. By Function
    • 7.2.5.7.3. By Type
    • 7.2.5.7.4. By Application
    • 7.2.5.8. Singapore
    • 7.2.5.8.1. By Source
    • 7.2.5.8.2. By Function
    • 7.2.5.8.3. By Type
    • 7.2.5.8.4. By Application
    • 7.2.5.9. Vietnam
    • 7.2.5.9.1. By Source
    • 7.2.5.9.2. By Function
    • 7.2.5.9.3. By Type
    • 7.2.5.9.4. By Application
    • 7.2.5.10. Rest of APAC
    • 7.2.5.10.1. By Source
    • 7.2.5.10.2. By Function
    • 7.2.5.10.3. By Type
    • 7.2.5.10.4. By Application

8. Latin America Pharmaceutical Gelatin Market

• 8.1. Market Size & Forecast, 2019-2029
  • 8.1.1. By Value (USD Million)
• 8.2. Market Share & Forecast
  • 8.2.1. By Source
  • 8.2.2. By Function
  • 8.2.3. By Type
  • 8.2.4. By Application
  • 8.2.5. By Country
    • 8.2.5.1. Brazil
    • 8.2.5.1.1. By Source
    • 8.2.5.1.2. By Function
    • 8.2.5.1.3. By Type
    • 8.2.5.1.4. By Application
    • 8.2.5.2. Mexico
    • 8.2.5.2.1. By Source
    • 8.2.5.2.2. By Function
    • 8.2.5.2.3. By Type
    • 8.2.5.2.4. By Application
    • 8.2.5.3. Argentina
    • 8.2.5.3.1. By Source
    • 8.2.5.3.2. By Function
    • 8.2.5.3.3. By Type
    • 8.2.5.3.4. By Application
    • 8.2.5.4. Peru
    • 8.2.5.4.1. By Source
    • 8.2.5.4.2. By Function
    • 8.2.5.4.3. By Type
    • 8.2.5.4.4. By Application
    • 8.2.5.5. Rest of LATAM
    • 8.2.5.5.1. By Source
    • 8.2.5.5.2. By Function
    • 8.2.5.5.3. By Type
    • 8.2.5.5.4. By Application

9. Middle East & Africa Pharmaceutical Gelatin Market

• 9.1. Market Size & Forecast, 2019-2029
  • 9.1.1. By Value (USD Million)
• 9.2. Market Share & Forecast
  • 9.2.1. By Source
  • 9.2.2. By Function
  • 9.2.3. By Type
  • 9.2.4. By Application
  • 9.2.5. By Country
    • 9.2.5.1. Saudi Arabia
    • 9.2.5.1.1. By Source
    • 9.2.5.1.2. By Function
    • 9.2.5.1.3. By Type
    • 9.2.5.1.4. By Application
    • 9.2.5.2. UAE
    • 9.2.5.2.1. By Source
    • 9.2.5.2.2. By Function
    • 9.2.5.2.3. By Type
    • 9.2.5.2.4. By Application
    • 9.2.5.3. Qatar
    • 9.2.5.3.1. By Source
    • 9.2.5.3.2. By Function
    • 9.2.5.3.3. By Type
    • 9.2.5.3.4. By Application
    • 9.2.5.4. Kuwait
    • 9.2.5.4.1. By Source
    • 9.2.5.4.2. By Function
    • 9.2.5.4.3. By Type
    • 9.2.5.4.4. By Application
    • 9.2.5.5. South Africa
    • 9.2.5.5.1. By Source
    • 9.2.5.5.2. By Function
    • 9.2.5.5.3. By Type
    • 9.2.5.5.4. By Application
    • 9.2.5.6. Nigeria
    • 9.2.5.6.1. By Source
    • 9.2.5.6.2. By Function
    • 9.2.5.6.3. By Type
    • 9.2.5.6.4. By Application
    • 9.2.5.7. Algeria
    • 9.2.5.7.1. By Source
    • 9.2.5.7.2. By Function
    • 9.2.5.7.3. By Type
    • 9.2.5.7.4. By Application
    • 9.2.5.8. Rest of MEA
    • 9.2.5.8.1. By Source
    • 9.2.5.8.2. By Function
    • 9.2.5.8.3. By Type
    • 9.2.5.8.4. By Application

10. Competitive Landscape

• 10.1. List of Key Players and Their Sources
• 10.2. Global Pharmaceutical Gelatin Company Market Share Analysis, 2022
• 10.3. Competitive Benchmarking, By Operating Parameters
• 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Pharmaceutical Gelatin Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

• 12.1. Gelita AG
• 12.2. Trobas Pharmaceutical gelatine B.V
• 12.3. Rousselot
• 12.4. Weishardt
• 12.5. Sterling Gelatin
• 12.6. Catalent, Inc
• 12.7. Nitta Pharmaceutical gelatin India Limited
• 12.8. Aspire Pharmaceuticals
• 12.9. Junca Gelatines
• 12.10. Gelco International
• 12.11. Norland Products Inc
• 12.12. Lapi Gelatine S.p.a
• 12.13. Trobus Gelatine B.V.
• 12.14. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

• 14.1. Qualitative Research
  • 14.1.1. Primary & Secondary Research
• 14.2. Quantitative Research
• 14.3. Market Breakdown & Data Triangulation
  • 14.3.1. Secondary Research
  • 14.3.2. Primary Research
• 14.4. Breakdown of Primary Research Respondents, By Region
• 14.5. Assumptions & Limitations